dry%20eye%20syndrome
DRY EYE SYNDROME

Dry eye syndrome is a clinical condition wherein the patient experiences ocular and conjunctival irritation due to decreased tear production and/or excessive tear evaporation.
It is associated with increased osmolarity of the tear film and inflammation of the ocular surface.

Goal of treatments are to relieve symptoms of patients, to improve visual acuity & quality of life of patients, to restore ocular surface & tear film to normal homeostatic state and to correct the underlying defect.

Follow Up

  • The patient is advised to follow up, in order to assess their response to therapy, if there is a need to alter or adjust the treatment & to monitor structural ocular damage, as well as to provide reassurance
  • Frequency & extent of follow-up will depend on the severity of the disease, therapeutic approach & response to therapy

Counselling

  • Clinicians should provide their patients w/ proper instructions for their therapeutic regimens, as well as caution them about LASIK, as this may worsen their dry eye condition
    • May refer their patients to an appropriate specialist, if there are other causes or underlying conditions that would contribute to having dry eye 
  • Patients should be educated about the chronic nature of the disease & its process
    • Their compliance, understanding of the disease, risks for structural changes should periodically be reassessed
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.
Stephen Padilla, 2 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
3 days ago
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.